Navigation Links
Dyadic International Reports 2011 Second Quarter Financial Results
Date:8/4/2011

JUPITER, Fla., Aug. 4, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the quarter ended June 30, 2011. The financial information contained in this press release should be read in conjunction with the financial statements and related footnotes which have been posted on the OTC market website at www.otcmarkets.com/stock/DYAI/financials and on Dyadic's website at www.dyadic.com/wt/dyad/investors.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO)

Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "The second quarter was highlighted by two important transactions. We opened the quarter with our first significant research collaboration in biopharmaceuticals with Sanofi Pasteur and EnGen Bio to leverage Dyadic's C1 technology to produce certain vaccines. We closed the quarter with a research, development and license agreement with a major player in the animal feed industry to use C1 to produce new animal feed products. These and other transactions show the benefits of providing integrated solutions to our partners and customers which include research, licensing and product offerings. Finally, we added to the value and protection of our products and technologies with the issuance of several new U.S. patents."

Second Quarter Highlights

  • Total revenue for the second quarter increased approximately 35% over the same period last year
  • Gross profit for the second quarter increased by 81% over the same period last year as a result of higher license fee revenue, improved product margins and further cost controls and operational efficie
    '/>"/>

  • SOURCE Dyadic International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
    2. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
    3. Dyadic to Present at the World Congress on Industrial Biotechnology & Bioprocessing
    4. Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
    5. New U.S. Patent Issued to Dyadic International
    6. Dyadic International to Present at Advanced Biofuels Leadership Conference
    7. Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
    8. Dyadic International Reports 2010 Fiscal Year Financial Results
    9. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
    10. Dyadic International Reports 2010 Third Quarter Financial Results
    11. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... , March 31, 2015  Bayer HealthCare ... Institute of Massachusetts Institute of Technology (MIT) and ... discovery. The goal of this new part of ... genetics to help create new cardiovascular therapies. ... with the Broad Institute to the area of ...
    (Date:3/31/2015)... and NEW YORK ... (NASDAQ: PTBI ), a biopharmaceutical company advancing ... announced today that its Korean marketing partner, Hanmi ... marketing approval in Korea from the country,s Ministry ... Korea Testing & Research Institute (KTR) for MuGard, ...
    (Date:3/31/2015)... 2015 Today, Cryos International, the world’s ... their U.S. facilities and inventory from New York City ... experience, Cryos’ relocation is a reflection of their increasing ... Orlando was completed during the first weekend of spring, ... place on April 6. The new facility in the ...
    (Date:3/30/2015)... March 30, 2015 With recent advancements ... you the government, major companies are getting into the ... setting future mandates for renewable energy production, many homeowners ... , Solara Power is a new solar distribution company ... available that allow qualifying homeowners to enjoy the benefits ...
    Breaking Biology Technology:Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2
    ... Hagens, BODY WORLDS 2:,The Original Exhibition of Real ... this Saturday, February 2nd. The acclaimed exhibition,includes the ... a special feature on,the brain., BODY WORLDS ... healthy and unhealthy organs, body section and slices, ...
    ... Feb. 1 ,Genzyme Corp. (Nasdaq: GENZ ) and ... they have received clearance under the,Hart-Scott-Rodino Antitrust Improvements Act ... Based on this approval, Genzyme will pay,Isis $150 million ... for,$30 per share., Upon completion of final contracts, ...
    ... Therapeutics (Amex:,CXM) announced that it has completed ... and other accredited or qualified investors,that was ... Asset Management,Company acted as the sole placement ... http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), The securities were offered ...
    Cached Biology Technology:Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 3Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 4Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4
    (Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
    (Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
    (Date:3/17/2015)... 2015 MedNet Solutions , a ... study management systems, is pleased to announce that ... Outsourcing in Clinical Trials Southeast conference – March ... excellent forum for MedNet to showcase iMedNet ... (SaaS) eClinical technology platform. We strongly ...
    Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
    ... of mythological beliefs. Some cultures prize them for their ... as dagger handles or good luck charms. But new ... by explaining how the horn gets its distinctive curve ... details about the structural materials that form the horn ...
    ... of Michigan Medical School have discovered a previously unknown ... and renal failure in children: recessive mutations in a ... the mutant gene is important to scientists because PLCE1 ... a vital role in the kidney's ability to remove ...
    ... found that aged mice undergoing weekly light-cycle shifts--similar to ... shift work--experienced significantly higher death rates than did old ... same eight-week period. The findings may not come as ... the research nonetheless provides, in rather stark terms, new ...
    Cached Biology News:Scientists crack rhino horn riddle 2Mutant gene causes severe kidney disease in infants 2Mutant gene causes severe kidney disease in infants 3Mutant gene causes severe kidney disease in infants 4Chronic jet-lag conditions hasten death in aged mice 2
    ... Each kit contains sufficient materials for 1,464 array ... Membrane: 4 each , Blocker BSA ... Goat Anti-Mouse Antibody, HRP-conjugated: 10 g ... , 10% Tween-20: 2 x 10 ml ...
    ... Accurate Results Laser Capture Microdissection (LCM) ... and accuracy of molecular assays by starting ... multi-cellular structures isolated from whole tissue or ... in 1996 at the National Institutes of ...
    Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
    ... can design custom microarrays to detect alternative ... Proprietary algorithms are used to identify ... high quality, spliced cDNAs aligned to the ... a custom SpliceArray is profiled with a ...
    Biology Products: